Electrophysiologist Dr. Mark Harvey To Retire After More Than 30 Years
OKLAHOMA CITY – One of the original founding physicians of the Oklahoma Heart Hospital, Dr. Mark Harvey, has announced his retirement effective in June after more than 30 years as a cardiac electrophysiologist.
Dr. Harvey grew up in Oklahoma City and began his pre-med work, earning a Bachelor of Science from Abilene Christian University in Texas. Upon graduation, he pursued a Ph.D. From the University of Texas Graduate School of Biomedical Sciences in Houston. He returned to Oklahoma for medical school at the University of Oklahoma College of Medicine and completed an internship in surgery at Mount Sinai Medical Center in New York. He then completed a Residency in Internal Medicine at the University of Michigan Medical Center in Ann Arbor. He stayed at the University of Michigan for his Fellowship in Cardiology and Cardiac Electrophysiology.
Dr. Harvey’s first position as a Cardiac Electrophysiology physician was at the North Texas Heart Center in Dallas. In 1998, he joined Oklahoma Cardiovascular Associates, the organization that founded Oklahoma Heart Hospital. OHH was founded in 2002. In 2003, he was named Director of the newly formed Oklahoma Foundation for Cardiovascular Research, where he served as an investigator on several studies of arrhythmia treatments and implantable cardiac device therapies.
“Dr. Mark Harvey’s experience and commitment to bringing the best and latest technologies to the electrical system of his patients’ hearts always keeps Oklahoma Heart Hospital on the leading edge of advancements in the diagnoses and treatment of cardiac rhythm disorders,” said Dr. John Harvey, OHH President and CEO.
Dr. Harvey’s passion for discovery and research took a dramatic new direction with the birth of his first two children, who were diagnosed with cystic fibrosis, a genetic disease that primarily affects the lungs and pancreas. He and his wife, Diane, became deeply involved with the Cystic Fibrosis Foundation at the local and national level. In 2026, Dr. Harvey was named the winner of the 2025 Big Dream award from the National Cystic Fibrosis Foundation for his work fighting the disease. In honoring Dr. Harvey, the Foundation noted, “Dr. Harvey brings both professional excellence and personal conviction to his work with the Cystic Fibrosis Foundation. His family’s journey with the disease inspired a lifelong commitment to help those living with CF not only survive – but thrive.” Dr. Harvey’s children benefit greatly from recently discovered advances in the treatment of CF and are now adults. He has a third child who is about to graduate from high school.
“As I retired from my work as a cardiac electrophysiologist at OHH, my medical career is taking an amazing turn to concentrate on my career-long commitment to scientific discovery,” said Dr. Harvey. “I plan to stay very active as a research physician through the Oklahoma City-based Harvey Family Foundation. My father, Ralph Harvey, formed the Harvey Family Foundation to continue his lifelong commitment to generosity and gratitude. The foundation has enabled our family to give to the scientific community that has given our children such vibrant lives.”
Dr. Harvey also plans to continue his work with the Cystic Fibrosis Foundation, exploring newly recognized complications of adults with cystic fibrosis, and investing in RNA and DNA therapies.